Mayne Pharma Group
ASX:MYX
$ 2,24
+ $0,08 (3,70%)
2,24 $
+$0,08 (3,70%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,78
Earnings Per Share
$5,02
Revenue Per Share
60,59%
Gross Margin %
$0,18 B
Market Cap
$0,03 B
Long-Term Debt
Earnings Per Share
$-0,78
Revenue Per Share
$5,02
Gross Margin %
60,59%
Market Cap
$0,18 B
Long-Term Debt
$0,03 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2011
EPS Earnings Per Share $-0,78 $-1,87 $-2,93 $-1,53 $-0,36 $-0,17 $0,19 $0,82 $1,24 $1,12 $0,33 $0,65 $0,34 $0,40
Earnings Earnings $-63,38M $-151,94M $-244,42M $-135,01M $-31,77M $-14,27M $15,04M $64,16M $93,68M $45,36M $12,98M $19,06M $9,57M $3,04M
RPS Revenue Per Share $0,00 $5,02 $4,78 $2,20 $4,81 $4,54 $5,44 $6,64 $6,78 $7,58 $6,60 $3,59 $4,88 $2,99 $6,60
Revenue Revenue $0,00M $408,10M $388,40M $183,59M $424,80M $400,80M $457,00M $525,21M $530,31M $572,60M $267,28M $141,42M $143,25M $84,07M $50,10M
OCF Operating Cash Flow $0,00M $17,47M $15,30M $-42,71M $-7,21M $58,86M $99,78M $106,61M $121,50M $-15,24M $53,50M $22,42M $26,14M $6,80M $0,00M
FCF Free Cash Flow $0,00M $0,00M $0,00M $-51,05M $-17,22M $41,77M $43,90M $94,69M $67,32M $-119,65M $-19,63M $-73,08M $21,93M $0,00M $0,00M
OM Operating Margin 0,00% -5,40% -11,47% -99,92% -77,97% -3,09% -2,87% 3,99% 12,20% 20,43% 17,15% 10,91% 21,49% 14,12% 3,40%
GM % Gross Margin % 0,00% 60,59% 56,33% 45,48% 45,54% 45,41% 46,28% 55,38% 52,22% 55,15% 62,99% 56,56% 52,39% 46,73% 43,86%
FCFS Free Cash Flow Per Share $0,00 $-0,15 $-0,45 $-3,19 $-0,23 $0,43 $0,86 $0,33 $0,37 $-15,33 $-0,24 $-1,87 $-0,32 $-0,70 $0,26
LT Debt Long-Term Debt N/A $31,64M $31,64M $28,48M N/A $285,80M $344,42M $318,50M $374,11M $327,04M $76,16M $60,78M $45,66M $39,23M N/A
Sha. Stocks 81,25M 81,25M 81,25M 83,42M 88,24M 88,24M 83,95M 79,15M 78,24M 75,55M 40,5M 39,34M 29,33M 28,15M 7,59M
×